Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 19, 2021
[ Fri, Feb 19th 2021
] - WOPRAI
[ Fri, Feb 19th 2021
] - WOPRAI
[ Fri, Feb 19th 2021
] - WOPRAI
[ Fri, Feb 19th 2021
] - WOPRAI
[ Fri, Feb 19th 2021
] - WOPRAI
[ Fri, Feb 19th 2021
] - WOPRAI
Thu, February 18, 2021
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
Patrick Donnelly Maintained (TXG) at Strong Buy with Increased Target to $240 on, Feb 18th, 2021
Patrick Donnelly of Citigroup, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Increased Target from $195 to $240 on, Feb 18th, 2021.
Patrick has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020
This is the rating of the analyst that currently disagrees with Patrick
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020
